Sunshine Biopharma Inc. Diluted Shares Outstanding (Weighted Average)
Sunshine Biopharma Inc. (SBFM) reported Diluted Shares Outstanding (Weighted Average) of 3.93 million shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-11-13
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 3.60M shares, a 8714.19% increase year-over-year.
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 2.70M shares, a 321.53% increase year-over-year.
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 2.15M shares.
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 1.27M shares, a 9768.16% increase year-over-year.
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 701.75K shares, a 5371.73% increase from fiscal 2023.
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 12.82K shares, a 99.92% decline from fiscal 2022.
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 15.18M shares, a 481.18% increase from fiscal 2021.
- Sunshine Biopharma Inc. weighted average number of shares outstanding, diluted for fiscal 2021 was 2.61M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | 3.93M shares 10-Q · filed 2025-11-13 | |||||
| 2025-06-30 | 3.60M shares 10-Q · filed 2025-08-12 | 3.15M shares derived: average of 2 quarters · filed 2025-08-12 | 2.82M shares derived: average of 3 quarters · filed 2025-08-12 | 2.43M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2025-03-31 | 2.70M shares 10-Q · filed 2025-05-15 | 2.43M shares derived: average of 2 quarters · filed 2025-05-15 | 2.04M shares derived: average of 3 quarters · filed 2025-05-15 | 1.54M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-12-31 | 2.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | 1.71M shares derived: average of 2 quarters · filed 2025-04-01 | 1.15M shares derived: average of 3 quarters · filed 2025-08-12 | 701.75K shares 10-K · filed 2025-04-01 | ||
| 2024-09-30 | 1.27M shares 10-Q · filed 2024-11-05 | 654.23K shares derived: average of 2 quarters · filed 2025-08-12 | 218.63K shares 10-Q · filed 2025-11-13 | -17.88M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-06-30 | 40.90K shares 10-Q · filed 2025-08-12 | 49.73K shares 10-Q · filed 2024-08-16 | 341.10K shares derived: average of 2 quarters · filed 2025-08-12 | -24.26M shares derived: average of 3 quarters · filed 2025-08-12 | -18.19M shares derived: average of 4 quarters · filed 2025-08-12 | |
| 2024-03-31 | 641.31K shares 10-Q · filed 2025-05-15 | -36.41M shares derived: average of 2 quarters · filed 2025-05-15 | -24.27M shares derived: average of 3 quarters · filed 2025-05-15 | -18.20M shares derived: average of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -73.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | -36.73M shares derived: average of 2 quarters · filed 2025-04-01 | -24.48M shares derived: average of 3 quarters · filed 2025-04-01 | 12.82K shares 10-K · filed 2025-04-01 | 24.33M shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 12.85K shares 10-Q · filed 2024-11-05 | 25.69M shares 10-Q · filed 2023-11-13 | 12.76K shares derived: average of 2 quarters · filed 2024-11-05 | 24.51M shares 10-Q · filed 2023-11-13 | 5.65M shares derived: average of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | 12.68K shares 10-Q/A · filed 2024-08-20 | 25.35M shares 10-Q · filed 2023-08-10 | 23.83M shares 10-Q · filed 2023-08-10 | 7.53M shares derived: average of 3 quarters · filed 2024-08-20 | 10.37M shares derived: average of 4 quarters · filed 2024-08-20 | |
| 2023-03-31 | 220.36K shares 10-Q · filed 2024-05-20 | 22.04M shares 10-Q · filed 2023-05-10 | 11.29M shares derived: average of 2 quarters · filed 2024-05-20 | 13.82M shares derived: average of 3 quarters · filed 2024-05-20 | 14.33M shares derived: average of 4 quarters · filed 2024-05-20 | |
| 2022-12-31 | 22.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 20.62M shares derived: average of 2 quarters · filed 2024-03-28 | 19.03M shares derived: average of 3 quarters · filed 2024-03-28 | 15.18M shares 10-K · filed 2024-03-28 | ||
| 2022-09-30 | 18.89M shares 10-Q · filed 2023-11-13 | 17.37M shares derived: average of 2 quarters · filed 2023-11-13 | 12.79M shares 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | 15.85M shares 10-Q · filed 2023-08-10 | 9.69M shares 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | 5.27M shares 10-Q · filed 2023-05-10 | |||||
| 2021-12-31 | 2.61M shares 10-K · filed 2023-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |